Facilitated By

San Antonio Medical Foundation

A PHASE 2 DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF GS 4997 IN SUBJECTS WITH DIABETIC KIDNEY DISEASE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Hura,Claudia E.
Funded by
GILEAD SCIENCE
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity